GlaxoSmithKline S.A.E's latest marketcap:
As of 08/31/2026, GlaxoSmithKline S.A.E's market capitalization has reached $678.06 M. According to our data, GlaxoSmithKline S.A.E is the 13152th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 678.06 M |
| Revenue (ttm) | 71.13 M |
| Net Income (ttm) | 3.82 M |
| Shares Out | 83.51 M |
| EPS (ttm) | 0.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 01/12/2026 |
| Earnings Date | 11/16/2026 |
GlaxoSmithKline S.A.E's yearly market capitalization.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/31/2026 | 34.49 B | $678.06 M | 12.54% | 13152 |
| 12/31/2025 | 5.32 B | $111.98 M | 76.81% | 26816 |
| 12/31/2024 | 3.01 B | $57.63 M | 1.27% | 27016 |
| 12/31/2023 | 2.97 B | $94.44 M | -6.84% | 23429 |
| 12/29/2022 | 3.19 B | $127.22 M | 23.58% | 20741 |
| 12/30/2021 | 2.58 B | $163.04 M | 82.08% | 20058 |
| 12/31/2020 | 1.42 B | $0 | -14.17% | 21248 |
| 12/31/2019 | 1.65 B | $102.1 M | 0% | 18014 |
| 12/18/2018 | 1.65 B | $91.41 M | 15.56% | 17720 |
| 12/28/2017 | 1.43 B | $79.43 M | 81.72% | 19163 |
Company Profile
About GlaxoSmithKline S.A.E.
GlaxoSmithKline S.A.E. is a leading pharmaceutical company specializing in the production of pharmaceutical chemicals. The company is renowned for its expertise in manufacturing a wide range of medicines and vaccines, catering to both general and specialty healthcare needs.
Key Highlights
- Founded: 1981
- Headquarters: London, United Kingdom
- Parent Company: Operates as a subsidiary of Glaxo Group Limited
With decades of experience in the pharmaceutical industry, GlaxoSmithKline S.A.E. continues to play a pivotal role in advancing healthcare solutions globally.
Frequently Asked Questions
-
What is GlaxoSmithKline S.A.E's (EGX-BIOC) current market cap?As of 08/31/2026, GlaxoSmithKline S.A.E (including the parent company, if applicable) has an estimated market capitalization of $678.06 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GlaxoSmithKline S.A.E (EGX-BIOC) rank globally by market cap?GlaxoSmithKline S.A.E global market capitalization ranking is approximately 13152 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.